FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)

View source ↗

Summary

The FDA approved a supplemental application for NPLATE (romiplostim) submitted by Amgen, Inc. The notice does not specify new indications or changes in this exc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Nplate (romiplostim)

Snippet

SUPPL AP for NPLATE (ROMIPLOSTIM)